Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Nuvectra Corporation (NVTR)

1.85   0.06 (3.35%) 10-21 16:00
Open: 1.79 Pre. Close: 1.79
High: 1.9062 Low: 1.71
Volume: 751,676 Market Cap: 37M
Nuvectra Corp is a medical device company in the United States. It manufactures devices to address chronic neurological disorders.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.912 - 1.919 1.919 - 1.925
Low: 1.692 - 1.701 1.701 - 1.707
Close: 1.837 - 1.85 1.85 - 1.861

Technical analysis

as of: 2019-10-21 4:37:45 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 2.55     One year: 2.97
Support: Support1: 1.60    Support2: 1.24
Resistance: Resistance1: 2.18    Resistance2: 2.55
Pivot: 1.45
Moving Average: MA(5): 1.63     MA(20): 1.42
MA(100): 2.25     MA(250): 8.85
MACD: MACD(12,26): 0.02     Signal(9): -0.06
Stochastic oscillator: %K(14,3): 60.20     %D(3): 71.01
RSI: RSI(14): 64.08
52-week: High: 22.08  Low: 1.24  Change(%): -91.1
Average Vol(K): 3-Month: 69996  10-Days: 90737

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
NVTR has closed above the upper band by 11.6%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 28.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

The Daily Biotech Pulse: ESMO Conference Gets Underway, J&J's Darzalex Snags Another Approval, Kaleido Biosciences CFO To Leave
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Sept. 26.) AstraZeneca plc (NYSE: AZN ) GlaxoSmithKline plc (NYSE: GSK ) Sanofi SA (NASDAQ: SNY ) ZEALAND PHARMA/S ADR (NASDAQ: ZEAL ) Down In The Dumps (Biotech stocks that hit 52-week lows Sept. 26.) ABIOMED, Inc. (NASDAQ: ABMD ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) Aduro BioTech Inc (NASDAQ: ADRO ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Akcea Therapeutics Inc (NASDAQ: AKCA ) Amicus Therapeutics, Inc. (NASDAQ: FOLD ) AnaptysBio Inc (NASDAQ: ANAB ) Aridis Pharmaceuticals Inc (NASDAQ: ARDS ) AzurRx BioPharma Inc (NASDAQ: AZRX ) Bellerophon Therapeutics Inc (NASDAQ: BLPH ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) (announced submission of clinical trial application to U.K. regulators for its investigational therapy for phenylketonuria) BioNano Genomics Inc (NASDAQ: BNGO ) BridgeBio Pharma Inc (NASDAQ: BBIO ) Calithera Biosciences Inc (NASDAQ: CALA ) Catalyst Biosciences Inc (NASDAQ: CBIO ) Cellectis SA (NASDAQ: CLLS ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Corvus Pharmaceuticals Inc (NASDAQ: CRVS ) CytomX Therapeutics Inc (NASDAQ: CTMX ) strong>DiaMedica Therapeutics Inc (NASDAQ: DMAC ) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX ) Enanta Pharmaceuticals Inc (NASDAQ: ENTA ) ( announced mid-stage results of NASH treatment candidate) Enochian Biosciences Inc (NASDAQ: ENOB ) Erytech Pharma SA (NASDAQ: ERYP ) Five Prime Therapeutics Inc (NASDAQ: FPRX ) Gemphire Therapeutics Inc (NASDAQ: GEMP ) Gritstone Oncology Inc (NASDAQ: GRTS ) HTG Molecular Diagnostics Inc (NASDAQ: HTGM ) IGM Biosciences Inc (NASDAQ: IGMS ) (initial public offering on Sept.

The Daily Biotech Pulse: Enanta Aces Midstage NASH Study, Takeda's Ulcerative Colitis Drug Found Superior To AbbVie's, Decision Day For J&J
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Sept. 25.) Coherus Biosciences Inc (NASDAQ: CHRS ) The Medicines Company (NASDAQ: MDCO ) Down In The Dumps (Biotech stocks that hit 52-week lows Sept. 25.) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) Advaxis, Inc. (NASDAQ: ADXS ) AnaptysBio Inc (NASDAQ: ANAB ) Aridis Pharmaceuticals Inc (NASDAQ: ARDS ) AzurRx BioPharma Inc (NASDAQ: AZRX ) ( announced lackadaisical efficacy data for pancreatic insufficiency drug) BridgeBio Pharma Inc (NASDAQ: BBIO ) Calithera Biosciences Inc (NASDAQ: CALA ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Catalyst Biosciences Inc (NASDAQ: CBIO ) Cellectis SA (NASDAQ: CLLS ) CytomX Therapeutics Inc (NASDAQ: CTMX ) DelMar Pharmaceuticals Inc (NASDAQ: DMPI ) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX ) Exagen Inc (NASDAQ: XGN ) (IPOed on Sep. 16) Five Prime Therapeutics Inc (NASDAQ: FPRX ) Fulcrum Therapeutics Inc (NASDAQ: FULC ) Gemphire Therapeutics Inc (NASDAQ: GEMP ) Kalvista Pharmaceuticals Inc (NASDAQ: KALV ) Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA ) Myovant Sciences Ltd (NYSE: MYOV ) Neon Therapeutics Inc (NASDAQ: NTGN ) Novelion Therapeutics Inc (NASDAQ: NVLN ) Nuvectra Corp (NASDAQ: NVTR ) Onconova Therapeutics Inc (NASDAQ: ONTX ) PDS Biotechnology Corp (NASDAQ: PDSB ) Plus Therapeutics Inc (NASDAQ: PSTV ) Sarepta Therapeutics Inc (NASDAQ: SRPT ) Seelos Therapeutics Inc (NASDAQ: SEEL ) Sophiris Bio Inc (NASDAQ: SPHS ) Spring Bank Pharmaceuticals Inc (NASDAQ: SBPH ) Stealth BioTherapeutics Corp (NASDAQ: MITO ) Surface Oncology Inc (NASDAQ: SURF ) Tocagen Inc (NASDAQ: TOCA ) Titan Pharmaceuticals, Inc. (NASDAQ: TTNP ) Urogen Pharma Ltd (NASDAQ: URGN ) Vaxart Inc (NASDAQ: VXRT ) (announced positive topline results for an early-stage …

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. (M) 17.89
Shares Float (M) 17.28
% Held by Insiders 3.57
% Held by Institutions 80.68
Shares Short (K) 1530
Shares Short P. Month (K)

Stock Financials

EPS -2.845
Book Value (p.s.) 3.890
PEG Ratio
Profit Margin -101.72
Operating Margin -89.24
Return on Assets (ttm) -24.1
Return on Equity (ttm) -83.4
Qtrly Rev. Growth 3.7
Gross Profit (p.s.) 1.444
Sales Per Share
EBITDA (p.s.) -2.460
Qtrly Earnings Growth
Operating Cash Flow (M) -47.97
Levered Free Cash Flow (M) -30.85

Stock Valuations

P/E -0.65
P/E Growth Ratio 0.03
P/BV 0.48
P/S 11862545.00
P/CF -0.69

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.